Individual results vary significantly between patients
Accordingly, and in line with currently ongoing trials in HFpEF (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not
Another study has reported that treatment of the DPP-4 inhibitor vildagliptin (10 mg/kg) in STZ-induced diabetic rats suppresses plasma TNF- concentrations and inhibits nitric oxide concentrations in the serum ( In the brain, GLP-1 treatment has a preventive effect on the progression of Alzheimers disease pathology in rats (Iwai et al., 2014
The lawsuits involve claims that Ozempic and other GLP-1 receptor agonist drugs, including Wegovy and Mounjaro, caused serious gastrointestinal injuries such as gastroparesis, or stomach paralysis
Some days she only managed protein shakes and Greek yogurt
For example, a 2025 study showed an average loss of 7.9 to 12 lbs in PCOS patients